MediciNova, Inc. (MNOV)
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. The company has collaboration agreements with Kissei Pharmaceutical Co., Ltd.; Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals Ltd.; and Meiji Seika Kaisha Ltd. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
$82.89M
Dr. Yuichi Iwaki M.D., Ph.D.
11.00
La Jolla, CA
Dec 01, 2006
-10.56
$-0.16
17.78
18.24
-3,598.59%
-10.15
-0.97
1.44
365.32
18.24
-13.52%
-13.37%
Similar stocks (9)
Eliem Therapeutics, Inc.
ELYM
PepGen Inc.
PEPG
Rezolute, Inc.
RZLT
Acrivon Therapeutics, Inc. Common Stock
ACRV
PMV Pharmaceuticals, Inc.
PMVP
Champions Oncology, Inc.
CSBR
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
AN2 Therapeutics, Inc.
ANTX
ETF Exposure (4)
iShares Micro-Cap ETF
IWC
0.02256%
Dimensional U.S. Core Equity 2 ETF
DFAC
8.813e-5%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (9)
Eliem Therapeutics, Inc.
ELYM
PepGen Inc.
PEPG
Rezolute, Inc.
RZLT
Acrivon Therapeutics, Inc. Common Stock
ACRV
PMV Pharmaceuticals, Inc.
PMVP
Champions Oncology, Inc.
CSBR
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
AN2 Therapeutics, Inc.
ANTX
ETF Exposure (4)
iShares Micro-Cap ETF
IWC
0.02256%
Dimensional U.S. Core Equity 2 ETF
DFAC
8.813e-5%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%